Dr. Beitsch studied at the University of Texas Southwestern Medical School in Dallas graduating third in his class. Following an internship and residency in general surgery at UT Southwestern, Dr. Beitsch completed a National Cancer Institute fellowship at M.D. Anderson Cancer Center in Houston as well as, a surgical oncology fellowship at the John Wayne Cancer Institute in Santa Monica, California.
He is an ASBS certified breast ultrasonographer and is an American College of Surgeons breast ultrasound faculty instructor. He trained with the father of sentinel lymph node biopsy in Los Angeles, Dr. Donald Morton and brought the technique to Dallas. Dr. Beitsch has given numerous national and local presentations and is actively involved in research. He has major articles in peer-reviewed medical journals including the New England Journal of Medicine, The Proceedings of the National Academy of Science, and the American Journal of Surgery.
Board certified in general surgery; Dr. Beitsch is in practice at Medical City Dallas Hospital. He has been local chairman of the Breast Cancer Detection Committee of the American Cancer Society and he has received their “Caring Spirit” Award because of his commitment to breast cancer prevention and treatment. He also received the Macy’s “Heart and Soul” Award for his work with the YWCA Breast Cancer Detection Project and the Founder’s Award of the Bridge Breast Program.
He is a fellow of the Society of Surgical Oncology, served as chairman of the Community Surgical Oncologist Committee and sat on the Executive Council from 2007-10. He is also a fellow of the American College of Surgeons where he is active in breast cancer research placing hundreds of women into cutting edge studies. He has served as the Membership Committee Chairman for the American Society of Breast Surgeons, was on the Board of Directors from 2006-9 and was the Program Director for the 2005 American Society of Breast Surgeons Annual Meeting in Los Angeles. He serves as the principle investigator of the National Mammosite Breast Radiation Registry
His other major area of research is in melanoma where he was an investigator in the Sunbelt Melanoma Trial accruing >100 patients and is currently the second largest accruer in the US to the Multicenter Selective Lymphadenectomy Trial II.